Study of IBI363 in Patients with Advanced First-line Gastric Cancer

Clinical trial NCT06610799 · RECRUITING

Trial details

NCT number: NCT06610799
Sponsor: Xiangdong Cheng
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

IBI363 + Chemotherapy

Start date: 2024-10-15
Primary completion: 2025-06-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.